Xiaoling Li

1.4k total citations
48 papers, 1.0k citations indexed

About

Xiaoling Li is a scholar working on Epidemiology, Molecular Biology and Immunology. According to data from OpenAlex, Xiaoling Li has authored 48 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Epidemiology, 8 papers in Molecular Biology and 8 papers in Immunology. Recurrent topics in Xiaoling Li's work include Hepatitis B Virus Studies (10 papers), Liver Disease Diagnosis and Treatment (10 papers) and Immune Response and Inflammation (6 papers). Xiaoling Li is often cited by papers focused on Hepatitis B Virus Studies (10 papers), Liver Disease Diagnosis and Treatment (10 papers) and Immune Response and Inflammation (6 papers). Xiaoling Li collaborates with scholars based in China, United States and United Kingdom. Xiaoling Li's co-authors include Mashkoor A. Choudhry, Bret A. Hassel, John A. Blackford, Irshad H. Chaudry, Martin G. Schwacha, Elizabeth J. Kovacs, Quan Yuan, Ningshao Xia, Helle Peegel and K.M.J. Menon and has published in prestigious journals such as Angewandte Chemie International Edition, PLoS ONE and Journal of Virology.

In The Last Decade

Xiaoling Li

46 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoling Li China 20 414 411 218 109 99 48 1.0k
Lin Wei China 22 331 0.8× 418 1.0× 384 1.8× 133 1.2× 121 1.2× 74 1.3k
Francesca Zerbini Italy 17 289 0.7× 363 0.9× 63 0.3× 81 0.7× 128 1.3× 38 1.0k
Jing Feng China 19 539 1.3× 554 1.3× 120 0.6× 182 1.7× 229 2.3× 84 1.6k
Jianxin Jiang China 19 214 0.5× 469 1.1× 177 0.8× 52 0.5× 159 1.6× 39 1.0k
David Ziring United States 14 209 0.5× 215 0.5× 226 1.0× 114 1.0× 52 0.5× 22 963
Qixing Chen China 24 337 0.8× 503 1.2× 524 2.4× 46 0.4× 87 0.9× 53 1.5k
Yukië Tanaka Japan 20 245 0.6× 476 1.2× 317 1.5× 157 1.4× 31 0.3× 68 1.3k
Ayesha Zahid Pakistan 12 378 0.9× 618 1.5× 289 1.3× 89 0.8× 45 0.5× 42 1.3k
Varun Kumar United States 13 204 0.5× 496 1.2× 198 0.9× 137 1.3× 24 0.2× 40 1.1k
Michael G. Dorrington Canada 12 254 0.6× 420 1.0× 646 3.0× 86 0.8× 121 1.2× 17 1.3k

Countries citing papers authored by Xiaoling Li

Since Specialization
Citations

This map shows the geographic impact of Xiaoling Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling Li more than expected).

Fields of papers citing papers by Xiaoling Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoling Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling Li. The network helps show where Xiaoling Li may publish in the future.

Co-authorship network of co-authors of Xiaoling Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoling Li. A scholar is included among the top collaborators of Xiaoling Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoling Li. Xiaoling Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Liting, Xueming Wang, Xianjun Li, Xiaoling Li, & Haipeng Li. (2025). Tirofiban plus aspirin in perforating artery cerebral infarction beyond time window: Effects on coagulation and clinical effect. Letters in Drug Design & Discovery. 22(3). 100025–100025.
2.
Li, Xiaoling, et al.. (2023). Corn peptides attenuate non-alcoholic fatty liver disease via PINK1/Parkin-mediated mitochondrial autophagy. Food & Nutrition Research. 67. 11 indexed citations
3.
Liu, Yiming, et al.. (2023). IFN-beta and EIF2AK2 are potential biomarkers for interstitial lung disease in anti-MDA5 positive dermatomyositis. Lara D. Veeken. 62(11). 3724–3731. 8 indexed citations
4.
Li, Xiaoling, et al.. (2022). Liver cyclophilin D deficiency inhibits the progression of early NASH by ameliorating steatosis and inflammation. Biochemical and Biophysical Research Communications. 594. 168–176. 11 indexed citations
5.
Li, Xiaoling, et al.. (2022). Post-marketing Surveillance of a Quadrivalent Influenza Vaccine (Vaxigrip Tetra) in South Korea. Infectious Diseases and Therapy. 11(5). 2035–2043. 1 indexed citations
6.
Chen, Jau‐Yuan, Szu‐Min Hsieh, Shinn‐Jang Hwang, et al.. (2022). Immunogenicity and safety of high-dose quadrivalent influenza vaccine in older adults in Taiwan: A phase III, randomized, multi-center study. Vaccine. 40(45). 6450–6454. 4 indexed citations
7.
8.
Wang, Yuze, Yunlong Song, Yifei Liu, et al.. (2020). SAMD4 family members suppress human hepatitis B virus by directly binding to the Smaug recognition region of viral RNA. Cellular and Molecular Immunology. 18(4). 1032–1044. 14 indexed citations
9.
Wu, Yingfen, Wei Fang, Le Tang, et al.. (2019). Herpesvirus acts with the cytoskeleton and promotes cancer progression. Journal of Cancer. 10(10). 2185–2193. 30 indexed citations
10.
Yuan, Lunzhi, Xuan Liu, Liang Zhang, et al.. (2018). A Chimeric Humanized Mouse Model by Engrafting the Human Induced Pluripotent Stem Cell-Derived Hepatocyte-Like Cell for the Chronic Hepatitis B Virus Infection. Frontiers in Microbiology. 9. 908–908. 27 indexed citations
11.
Liu, Jiaming, Suying Yan, Xiaoling Li, & Yuqin Wang. (2016). Application of the Global Trigger Tool in detecting adverse drug events. Zhonghua yiyuan guanli zazhi. 32(3). 195–199. 3 indexed citations
12.
Ou, Chunlin, Zhenqiang Sun, Han Zhang, et al.. (2015). SPLUNC1 reduces the inflammatory response of nasopharyngeal carcinoma cells infected with the EB virus by inhibiting the TLR9/NF-κB pathway. Oncology Reports. 33(6). 2779–2788. 25 indexed citations
13.
Li, Xiaoling, Adam M. Hammer, Juan L. Rendón, & Mashkoor A. Choudhry. (2015). Intestine Immune Homeostasis After Alcohol and Burn Injury. Shock. 43(6). 540–548. 13 indexed citations
14.
Yuan, Na, Lin Song, Shiming Zhang, et al.. (2014). Bafilomycin A1 targets both autophagy and apoptosis pathways in pediatric B-cell acute lymphoblastic leukemia. Haematologica. 100(3). 345–356. 150 indexed citations
15.
Li, Wenjuan, Xiaoling Li, Wei Wang, et al.. (2013). Tumor suppressor gene Oxidored-nitro domain-containing protein 1 regulates nasopharyngeal cancer cell autophagy, metabolism, and apoptosis in vitro. The International Journal of Biochemistry & Cell Biology. 45(9). 2016–2026. 21 indexed citations
16.
Li, Xiaoling, Suhail Akhtar, Elizabeth J. Kovacs, Richard L. Gamelli, & Mashkoor A. Choudhry. (2011). Inflammatory Response in Multiple Organs in a Mouse Model of Acute Alcohol Intoxication and Burn Injury. Journal of Burn Care & Research. 32(4). 489–497. 37 indexed citations
17.
Zhang, Rui, Mingguang He, Wei Liang, et al.. (2011). Self correction of refractive error among young people in rural China: results of cross sectional investigation. BMJ. 343(aug09 2). d4767–d4767. 25 indexed citations
18.
Li, Xiaoling, Martin G. Schwacha, Irshad H. Chaudry, & Mashkoor A. Choudhry. (2008). ACUTE ALCOHOL INTOXICATION POTENTIATES NEUTROPHIL-MEDIATED INTESTINAL TISSUE DAMAGE AFTER BURN INJURY. Shock. 29(3). 377–383. 39 indexed citations
19.
Chen, Hai, et al.. (2006). Seroprevalance and Identification of Influenza A Virus Infection from Migratory Wild Waterfowl in China (2004–2005). Journal of Veterinary Medicine Series B. 53(4). 166–170. 20 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lin Wei Breakdown of academic impact, for papers by Francesca Zerbini Breakdown of academic impact, for papers by Jing Feng Breakdown of academic impact, for papers by Jianxin Jiang Breakdown of academic impact, for papers by David Ziring Breakdown of academic impact, for papers by Qixing Chen Breakdown of academic impact, for papers by Yukië Tanaka Breakdown of academic impact, for papers by Ayesha Zahid Breakdown of academic impact, for papers by Varun Kumar Breakdown of academic impact, for papers by Michael G. Dorrington
Rankless by CCL
2026